Prophylactic platelet transfusions prior to surgery for people with a low platelet count

Cochrane Database of Systematic Reviews

Volumn 2018, Issue 9, 2018, Pages

  Estcourt, Lise J ^a   Malouf, Reem ^b   Doree, Carolyn ^a   Trivella, Marialena ^b   Hopewell, Sally ^b   Birchall, Janet ^c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPRESSIN; ELTROMBOPAG; ROMIPLOSTIM; ARGIPRESSIN[1 DEAMINO]; BENZOIC ACID; FC RECEPTOR; FUSION PROTEIN; HEMOSTATIC AGENT; HYDRAZINE DERIVATIVE; PYRAZOLE DERIVATIVE; THROMBOPOIETIN;

ALL CAUSE MORTALITY; BLEEDING; CLINICAL EFFECTIVENESS; ERYTHROCYTE TRANSFUSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LIVER DISEASE; PATIENT SAFETY; PLATELET COUNT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURGERY; SYSTEMATIC REVIEW; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOEMBOLISM; UNCERTAINTY; ADULT; COMPLICATION; META ANALYSIS; PLASMA; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PROCEDURES;

ADULT; BENZOATES; DEAMINO ARGININE VASOPRESSIN; HEMOSTATICS; HUMANS; HYDRAZINES; PLASMA; PLATELET TRANSFUSION; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PYRAZOLES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, FC; RECOMBINANT FUSION PROTEINS; THROMBOCYTOPENIA; THROMBOPOIETIN;

EID: 85053388118     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD012779.pub2     Document Type: Review

References (127)

1. Basu P, Nair T, Farhat S, Shah NJ, Krishnaswamy N. Single use of romiplostim thrombopoietin analogue in thrombocytopenia for liver biopsy in chronic liver disease-randomized clinical trial. Asian Pacific Digestive Week 2012;27:207-8. [DOI: dx.doi.org/10.1111/jgh.12006]9143129
2. Basu PP, Nair T, Farhat S, James Shah N, Jafri M, Foustin S. Single use of romiplostim thrombopoietin analogue in severe thrombocytopenia for outpatient percutaneous liver biopsy in patients with chronic liver disease-a randomized double blinded prospective trial. Journal of Hepatology 2012;56:S38. [DOI: dx.doi.org/10.1016/S0168-8278%2812%2960101-9]9143130
3. Basu PP, Nair T, Jafri M, Krishnaswamy NV, Farhat S, Shah NJ, Brown R. Single use of romiplostim thrombopoietin analogue (TPO) in severe thrombocytopenia for outpatient percutaneous liver biopsy in patients with chronic liver disease (CLD) - a randomized double blinded prospective clinical pilot trial. 18th Annual International Congress of the International Liver Transplantation Society, ILTS; 2012 May 15-19; San Francisco (CA). 2012; Vol. 18:S271. [DOI: dx.doi.org/10.1002/lt.23435]9143131
4. Basu PP, Nair T, Krishnaswamy N, James Shah N, Farhat S, Brown R. Single use of romiplostim thrombopoietin analogue (TPO) in severe thrombocytopenia for outpatient percutaneous liver biopsy in patients with chronic liver disease (CLD) - a randomized double blinded prospective clinical pilot trial. 76th Annual Scientific Meeting of the American College of Gastroenterology; 2011 Oct 28-Nov 2; Washington (DC). 2011, issue 106:S135-6. [DOI: dx.doi.org/10.1038/ajg.2011.336_5]9143132
5. Basu PP, Nair TJ, Krishnaswamy N, Shah NJ, Farhat S. Single use of romiplostim thrombopoietin analogue (TPO) in severe thrombocytopenia for outpatient percutaneous liver biopsy in patients with chronic liver disease (CLD) - a randomized double blinded prospective clinical pilot trial. 62nd Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting; 2011 Nov 4-8; San Francisco (CA). 2011, issue 54:898A. [DOI: dx.doi.org/10.1002/hep.24666]9143133
6. Basu PP, Nair TJ, Krishnaswamy NV, James Shah N, Brown RS. Single use of romiplostim thrombopoietin analogue (TPO) in severe thrombocytopenia for outpatient percutaneous liver biopsy in patients with chronic liver disease (CLD) - a randomized double-blinded prospective clinical pilot trial. 43rd Nordic Gastroenterology Congress; 2012 Jun 12-15; Reykjavik Iceland. 2012, issue 47:45-46. [DOI: dx.doi.org/10.3109/00365521.2012.697267]9143134
7. Basu PP, Nair TJ, Krishnaswamy NV, Shah NJ, Brown Jr RS. Single use of romiplostim thrombopoietin analogue (TPO) in severe thrombocytopenia for outpatient percutaneous liver biopsy in patients with chronic liver disease (CLD) - a randomized double blinded prospective clinical pilot trial. 2012 Scientific Session of the Society of American Gastrointestinal and Endoscopic Surgeons; 2012 Mar 7-10; San Diego (CA). 2012, issue 26:S333. [DOI: dx.doi.org/10.1007/s00464-012-2203-x]9143135
8. NCT00816127 . Prevention of bleeding in patient with cirrhosis undergoing dental extraction. clinicaltrials.gov/ct2/show/NCT00816127 Date first received: 29 December 2008. 9143137
9. Stanca CM, Montazem AH, Lawal A, Zhang JX, Schiano TD. Intranasal desmopressin versus blood transfusion in cirrhotic patients with coagulopathy undergoing dental extraction: a randomized controlled trial. Journal of Oral and Maxillofacial Surgery 2010;68(1):138-43. 9143138
10. Stanca CM, Montazem AH, Zhang JH, Lawal A, Schiano TD. Intranasal desmopressin is effective in preventing bleeding after dental extraction in cirrhotic patients having moderate degrees of coagulopathy. Transfusion 2006;46(4, Suppl 1):568A. 9143139
11. Veelo DP, Vlaar AP, Dongelmans DA, Binnekade JM, Levi M, Paulus F, et al. Correction of subclinical coagulation disorders before percutaneous dilatational tracheotomy. Blood Transfusion 2012;10:213-20. 9143141
12. Abdelfatah M. Management of chronic subdural hematoma in patients with intractable thrombocytopenia. Turkish Neurosurgery Journal 2016;18825(16):1-5. 9143143
13. Afdhal NH, Giannini EG, Tayyab G, Mohsin A, Lee JW, Andriulli A, et al. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. New England Journal of Medicine 2012;367:716-24. 9143145
14. Al-Zaabi M, Clark S, Gomez K, Sekhar M. Assessing risk of bleeding in thrombocytopenic patients requiring platelet transfusion prior to invasive procedures. Haematologica 2014;99(S1):199. 9143147
15. Backos M, Rai R, Baxter N, Chilcott IT, Cohen H, Regan L. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. British Journal of Obstetrics and Gynaecology 1999;106(2):102-7. 9143149
16. Barrera R, Mina B, Huang Y, Groeger JS. Acute complications of central line placement in profoundly thrombocytopenic cancer patients. Cancer 1996;78:2025-30. 9143151
17. 9/L who underwent laparoscopic splenectomy?. World Journal of Surgery 2014;38:2267-72. 9143153
18. Chantarangkul V, Primignani M, Lemma L, Clerici M, Jovani M, Rebulla P, et al. Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion. 58th Annual Meeting of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis; 2012 Jun 27-30; Liverpool, UK. 2013, issue 11:73. [DOI: dx.doi.org/10.1111/jth.12443]9143155
19. Chen X, Peng B, Cai Y, Zhou J, Wang Y, Wu Z, et al. Laparoscopic splenectomy for patients with immune thrombocytopenia and very low platelet count: is platelet transfusion necessary?. Journal of Surgical Research 2011;170(2):e225-32. 9143157
20. De Pietri L, Bianchini M, Montalti R, De Maria N, Di Maira T, Begliomini B, et al. Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial. Hepatology 2016;63:566-73. 9143159
21. Embrey KK, Davis CL, Rey MA, Lumb PD, Gold ME. Perioperative transfusion practices in women versus men. American Association of Nurse Anesthetists Journal 2006;74(5):393-4. 9143161
22. EudraCT 2007-005851-40. A randomised, double-blind, placebo-controlled, multi-centre study to evaluate the safety and efficacy of eltrombopag to reduce the need for platelet transfusion in thrombocytopenic subjects with chronic liver disease undergoing elective invasive procedures. www.clinicaltrialsregister.eu/ctr-search/trial/2007-005851-40/ES Date first registered: 3 December 2008. 9143163
23. Fayed NA, Abdallah AR, Khalil MK, Marwan IK. Therapeutic rather than prophylactic platelet transfusion policy for severe thrombocytopenia during liver transplantation. Platelets 2014;25(8):576-86. 9143165
24. Harding SA, Shakoor MA, Grindon AJ. Platelet support for cardiopulmonary bypass surgery. Journal of Thoracic and Cardiovascular Surgery 1975;70(2):350-3. 9143167
25. Hess R. Results of the pragmatic randomized optimal plasma and platelet ratios trial (PROPPR). British Blood Transfusion Society 2015;109:72. 9143169
26. Hibbert RM, Atwell TD, Lekah A, Patel MD, Carter RE, McDonald JS, et al. Safety of ultrasound-guided thoracentesis in patients with abnormal preprocedural coagulation parameters. Chest 2013;44(2):456-63. 9143171
27. Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 2015;3;(5):471-82. 9143173
28. Karkouti K, Callum J, Wijeysundera D, Rao V, Crowther M, Grocott H, et al. Point-of-care hemostatic testing in cardiac surgery a stepped-wedge clustered randomized controlled trial. Circulation 2016;134:1152-62. 9143175
29. Khair T, El-Haddad D, Srujal P, Marmagiolis K, Cilingiroglu M, Iliescu G, et al. Triple jeopardy: Heart disease, cancer and thrombocytopenia-fluoroscopic and echocardiographic guided pericardiocentesis in cancer patients with cardiac tamponade and thrombocytopenia. Catheterization and Cardiovascular Interventions 2015;85:S82-3. [DOI: dx.doi.org/10.1002/ccd.25910]9143177
30. Kultufan, Turan S, Aydinli B, Ayik I, Yagar S, Kazanci D, et al. The role of rotational thromboelastgraphy on decision of blood transfusion in open heart surgery [Acik kalp cerrahisinde tromboelastografinin transfuzyon karari Uzerine etkisi]. Gogus-Kalp-Damar Anestezi ve Yogun Bakim Dernegi Dergisi 2006;12(4):154-9. 9143179
31. Napolitano G, Iacobellis A, Merla A, Niro G, Valvano MR, Terracciano F, et al. Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia. European Journal of Internal Medicine 2017;38:79-82. 9143181
32. NCT00521664 . A trial comparing a prophylactic with a therapeutic platelet transfusion strategy in two groups. clinicaltrials.gov/ct2/show/NCT00521664 Date first received: 27 August 2007. 9143183
33. NCT00549484 . Thrombopoietin levels and platelet transfusion in neonates. clinicaltrials.gov/ct2/show/NCT00549484 Date first received: 24 October 2007. 9143185
34. NCT00678587 . Eltrombopagto reduce the need for platelet transfusion in subjects with chronic liver disease and thrombocytopenia undergoing elective invasive procedures (ELEVATE). clinicaltrials.gov/ct2/show/NCT00678587 First submitted 13 May 2008. 9143187
35. NCT01291290 . START - early thrombocyte administration to patients with ruptured abdominal aortic aneurism (rAAA). clinicaltrials.gov/ct2/show/NCT01291290 Date first received: 7 February 2011. 9143189
36. NCT01402739 . Monocentric pilot study of algorithm-guided transfusions in cardiac surgery patients for reduction of drainage blood losses. clinicaltrials.gov/ct2/show/NCT01402739 Date first received: 25 July 2011. 9143191
37. NCT01919840 . Blood products transfusion in cardiac surgery after the implementation of a coagulation monitoring system at patient bedside: thromboelastometry versus standard transfusion protocol (ROTEM-2010). clinicaltrials.gov/ct2/show/NCT01919840 Date first received: 12 April 2013. 9143193
38. NCT02042898 . Transfusion Requirements In Cardiac Surgery III (TRICS-III). clinicaltrials.gov/ct2/show/NCT02042898 Date first received: 17 January 2014. 9143195
39. NCT02074436 . Prevention of bleeding in hematological malignancies with antifibrinolytic (epsilon aminocaproic acid) (PROBLEMA). clinicaltrials.gov/ct2/show/NCT02074436 Date first received: 26 February 2014. 9143197
40. NCT02200419 . POC - Transfusion Algorithm Cardiac Study (TACS). clinicaltrials.gov/ct2/show/NCT02200419 Date first received: 20 June 2014. 9143199
41. NCT02352181 . Management of coagulopathy during orthotopic liver transplantation. Comparison between ROTEM-based management and standard biological assessment. clinicaltrials.gov/ct2/show/NCT02352181 Date first received: 18 December 2014. 9143201
42. NCT02987712 . Management of coagulopathy in cirrhotic patients undergoing invasive procedures. clinicaltrials.gov/ct2/show/NCT02987712 Date first received: 6 December 2016. 9143203
43. NCT02990273 . The utility of thromboelastography in cirrhotic patients undergoing endoscopic procedures. clinicaltrials.gov/ct2/show/NCT02990273 Date first received: 14 October 2016. 9143205
44. NCT03011827 . Transfusion prediction model in orthotopic liver transplantation based on thromboelastometry: prospective validation study. clinicaltrials.gov/ct2/show/NCT03011827 Date first received: 4 January 2017. 9143207
45. NCT03022253 . Platelet transfusion for treatment of patent ductus arteriosus in thrombocytopenic preterm neonates. clinicaltrials.gov/ct2/show/NCT03022253 Date first received: 25 June 2016. 9143209
46. Park JM, Oh HJ, Cho YK, Lee B-I, Cho YS, Choi M-G. Risk factor analysis of bleeding after endoscopic interventions in patients with chronic thrombocytopenia. Gastrointestinal Endoscopy 2016;83(1):AB205. 9143211
47. Pereboom IT, de Boer MT, Haagsma EB, Hendriks HG, Lisman T, Porte RJ. Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesthesia and Analgesia 2009;108(4):1083-91. 9143213
48. Perek B, Stefaniak S, Komosa A, Perek A, Katynska I, Jemielity M. Routine transfusion of platelet concentrates effectively reduces reoperation rate for bleeding and pericardial effusion after elective operations for ascending aortic aneurysm. Platelets 2016;27(8):764-70. 9143215
49. Perl VJ, Leroux B, Cook MR, Watson J, Fair K, Martin D, et al. Damage-control resuscitation and emergency laparotomy: findings from the PROPPR study. Journal of Trauma and Acute Care Surgery 2016;80(4):568-75. [DOI: dx.doi.org/10.1097/TA.0000000000000960]9143217
50. Pietri L, Bianchini M, Montalti R, Maria N, Maira T, Begliomini B, et al. Thrombelastography (TEG) decreases blood products requirement before invasive procedures in cirrhotic patients with coagulation tests derangement. A randomized controlled trial. Digestive and Liver Disease 2014;46(1):e5-e6. 9143219
51. Ray CE Jr, Shenoy SS. Patients with thrombocytopenia: outcome of radiologic placement of central venous access devices. Radiology 1997;204(1):97-9. 9143221
52. Simon TL, Akl B, Murphy W. Controlled trial of platelet concentrates in patients undergoing cardiopulmonary bypass. Transfusion 1982;22(5, S3):423. 9143223
53. Simon TL, Akl BF, Murphy W. Controlled trial of routine administration of platelet concentrates in cardiopulmonary bypass surgery. Annals of Thoracic Surgery 1984;37(5):359-64. 9143225
54. Smart L, Wellner M, Gray NA, Michaels A, Kirkpatrick RB, Conteh L, et al. A prospective, randomized clinical trial comparing blood product use, bleeding events, and cost during and after endoscopic procedures in patients with cirrhosis and coagulopathy: rotational thromboelastrometry (ROTEM) versus conventional therapy. Hepatology 2017;66(1):243A-4A. 9143227
55. Tanaka KA, Egan K, Szlam F, Ogawa S, Roback JD, Sreeram G, et al. Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion. Transfusion 2014;54(1):109-18. 9143229
56. Titano JJ, Biederman DM, Marinelli BS, Patel RS, Kim E, Tabori NE, et al. Safety and feasibility of transradial access for visceral interventions in patients with thrombocytopenia. Cardiovascular and Interventional Radiology 2016;39(5):676-82. 9143231
57. Tripodi A, Primignani M, Chantarangkul V, Lemma L, Jovani M, Rebulla P, et al. Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion. Cirrhosis and Liver Failure 2013;33:362-7. 9143233
58. NTR5653 . Prophylactic platelet transfusion prior to central venous catheter placement in patients with thrombocytopenia [Onderzoek naar de noodzaak van correctie van bloedplaatjestekort voor het plaatsen van een centraal veneuze lijn]. www.trialregister.nl/trialreg/admin/rctview.asp?TC=5653 Date first received: 27 January 2016. [www.trialregister.nl/trialreg/admin/rctview.asp?TC=5653]9143235
59. NCT02311985 . Comparison of three transfusion strategies for central venous catheterization in cirrhotics (POCKET). clinicaltrials.gov/ct2/show/NCT02311985 Date first received: 9 December 2014. 9143237
60. Rocha LL, Pessoa CMS, Neto AS, do Prado RR, Silva E, de Almeida MD, et al. Thromboelastometry versus standard coagulation tests versus restrictive protocol to guide blood transfusion prior to central venous catheterization in cirrhosis: study protocol for a randomized controlled trial. Trials 2017;18:85. [DOI: 10.1186/s13063-017-1835-5]9143238
61. Afdhal N, McHutchison J, Brown R, Jacobson I, Manns M, Poordad F, et al. Thrombocytopenia associated with chronic liver disease. Journal of Hepatology 2008;48(6):1000-7.
62. British Committee for Standards in Haematology. Guidelines for the use of platelet transfusions. British Journal of Haematology 2003;122(1):10-23.
63. Birchall J, Tinegate H, Regan F. Chapter 14 Acute transfusion reactions (ATR). In: Bolton-Maggs PHB, Poles D, et al. on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group, editor(s). The 2014 Annual SHOT Report. Manchester, UK: SHOT, 2015:106-12.
64. Blumberg N, Heal JM, Phillips GL. Platelet transfusions: trigger, dose, benefits and risks. F1000 Medicine Reports 2010;2:1-5.
65. Bolliger D, Seeberger MD, Tanaka KA. Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfusion Medicine Reviews 2012;26(1):1-13.
66. Bolton-Maggs PH, on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2015 Annual SHOT Report. SHOT 2016.
67. Burrows RF, Kelton JG. Thrombocytopenia at delivery: a prospective survey of 6715 deliveries. American Journal of Obstetrics and Gynecology 1990;162:731-4.
68. Cameron B, Rock G, Olberg B, Neurath D. Evaluation of platelet transfusion triggers in a tertiary-care hospital. Transfusion 2007;47(2):206-11.
69. Carless PA, Stokes BJ, Moxey AJ, Henry DA. Desmopressin use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD001884.pub2]
70. Chapman C. Transfusion-related lung injury (TRALI), 2015. www.shotuk.org/wp-content/uploads/SHOT-2014-Annual-Report_v11-Web-Edition.pdf (accessed 26 November 2015).
71. Veritas Health Innovation. Covidence systematic review software. Melbourne: Veritas Health Innovation, 2016.
72. Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
73. Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ. Alternatives to allogeneic platelet transfusion. British Journal of Haematology 2016;175:381-92.
74. Desborough MJ, Oakland K, Brierley C, Bennett S, Doree C, Trivella M, et al. Desmopressin use for minimising perioperative blood transfusion. Cochrane Database of Systematic Reviews 2017, Issue 7. [DOI: 10.1002/14651858.CD001884.pub3]
75. Engele LJ, Straat M, van Rooijen IH, de Vooght KM, Cremer OL, Schultz M, et al. Transfusion of platelets, but not of red blood cells, is independently associated with nosocomial infections in the critically ill. Annals of Intensive Care 2016;6:67. [DOI: 10.1186/s13613-016-0173-1.]
76. Effective Practice, Organisation of Care (EPOC). EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services 2015. epoc.cochrane.org/epoc-specific-resources-review-authors (accessed prior to 23 August 2018).
77. Estcourt LJ, Birchall J, Lowe D, Grant-Casey J, Rowley M, Murphy MF. Platelet transfusions in haematology patients: are we using them appropriately?. Vox Sanguinis 2012;103(4):284-93.
78. Estcourt LJ, Desborough M, Hopewell S, Doree C, Stanworth SJ. Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia. Cochrane Database of Systematic Reviews 2015, Issue 12. [DOI: 10.1002/14651858.CD011771.pub2]
79. Estcourt LJ, Desborough M, Brunskill SJ, Doree C, Hopewell S, Murphy MF, et al. Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders. Cochrane Database of Systematic Reviews 2016, Issue 3. [DOI: 10.1002/14651858.CD009733.pub3]
80. Estcourt LJ, Ingram C, Doree C, Trivella M, Stanworth SJ. Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia. Cochrane Database of Systematic Reviews 2016, Issue 5. [DOI: 10.1002/14651858.CD011980.pub2]
81. Estcourt LJ, Birchall J, Allard S, Bassey SJ, Hersey P, Kerr JP, et al. and the British Committee for Standards in Haematology. Guidelines for the use of platelet transfusions. British Journal of Haematology 2017;176:365-94. [DOI: 10.1111/bjh.14423]
82. Fabes J, Barker G, Simons G, Curry N, Brunskill SJ, Doree C, et al. Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD010649]
83. Fuller AK, Uglik KM, Braine HG, King KE. A comprehensive program to minimize platelet outdating. Transfusion 2011;51:1469-76. [DOI: 10.1111/j.1537-2995.2010.03039.x]
84. Gordon MS, Nemunaitis J, Hoffman R, Paquette RL, Rosenfeld C, Manfreda S, et al. A phase I trial of recombinant human interleukin-6 in patients with myelodysplastic syndromes and thrombocytopenia. Blood 1995;85:3066-76. 4442745
85. Greeno E, McCullough J, Weisdorf D. Platelet utilization and the transfusion trigger: a prospective analysis. Transfusion 2007;47:201-5. [DOI: 10.1111/j.1537-2995.2007.01089.x]
86. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD001886.pub4]
87. Higgins JP, Deeks JJ. Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
88. Higgins JP, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
89. Higgins JP, Deeks JJ, Altman DG. Chapter 16: Special topics in Statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
90. Hui P, Cook DJ, Lim W, Fraser GA, Arnold DM. The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest 2011;139(2):271-8.
91. Jacobs MR, Smith D, Heaton WA, Zantek ND, Good CE. Detection of bacterial contamination in prestorage culture-negative apheresis platelets on day of issue with the Pan Genera Detection test. Transfusion 2011;51(12):2573-82.
92. Joint Formulary Committee. British National Formulary, 2016. www.medicinescomplete.com/mc/bnf/current. Online. London: BMJ Group and Pharmaceutical Press, (accessed 17 March 2016).
93. Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, et al. Platelet transfusion: a clinical practice guideline from the AABB. Annals of Internal Medicine 2015;162(3):205-13.
94. Kurzrock R, Cortes J, Thomas DA, Jeha S, Pilat S, Talpaz M. Pilot study of low-dose interleukin-11 in patients with bone marrow failure. Journal of Clinical Oncology 2011;19(21):4165-72. 4442760
95. Kuter DJ. Milestones in understanding platelet production: a historical overview. British Journal of Haematology 2014;165(2):248-58.
96. Leguit RJ, van den Tweel JG. The pathology of bone marrow failure. Histopathology 2010;57(5):655-70.
97. Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Journal of Haematology 2009;145(1):24-33.
98. McNicol ED, Tzortzopoulou A, Schumann R, Carr DB, Kalra A. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Cochrane Database of Systematic Reviews 2016, Issue 9. [DOI: 10.1002/14651858.CD006883.pub3]
99. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of Internal Medicine 2009;151(4):264-9.
100. Neunert CE. Current management of immune thrombocytopenia. Hematology 2013;2013:276-82.
101. National Institute of Health and Care Excellence. Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura, 2011. www.nice.org.uk/guidance/ta221 (accessed prior to 23 August 2018).
102. National Institute of Health and Care Excellence. Eltrombopag for treating chronic immune (idiopathic) thrombocytopenic purpura (review of technology appraisal 205). www.nice.org.uk/guidance/ta293/documents/thrombocytopenic-purpura-eltrombopag-rev-ta205-final-appraisal-determination3 (accessed prior to 23 August 2018).
103. National Institute for Health and Care Excellence. Blood transfusion. www.nice.org.uk/guidance/ng24 (accessed 10 November 2016).
104. Nisha S, Amita D, Uma S, Tripathi AK, Pushplata S. Prevalence and characterization of thrombocytopenia in pregnancy in Indian women. Indian Journal of Hematology and Blood Transfusion 2012;28(2):77-81.
105. Pacheco LD, Berkowitz RL, Moise KJ, Bussel JB, McFarland JG, Saade GR. Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratification. Obstetrics and Gynecology 2011;118(5):1157-63.
106. Parmar M, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
107. Pendry K, Davies T. An audit of use and wastage in the north west of England and North Wales: where have all the platelets gone?. Blood and Transplant Matters 2011;34:17-9.
108. Perdigão JP, de Almeida PC, Rocha TD, Mota MR, Soares EC, Alves AP, et al. Postoperative bleeding after dental extraction in liver pretransplant patients. Journal of Oral and Maxillofacial Surgery 2012;70:e177-84.
109. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115(2):168-86.
110. Reeves BC, Deeks JJ, Higgins JP, Wells GA. Chapter 13: Including non-randomised studies. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
111. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
112. Sainio S, Kekomäki R, Riikonen S, Teramo K. Maternal thrombocytopenia at term: a population-based study. Acta Obstetricia et Gynecologica Scandinavica 2000;79:744-9.
113. Schünemann HJ, Oxman AD, Higgins JP, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
114. Schünemann HJ, Oxman AD, Vist GE, Higgins JP, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
115. Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD005011.pub4]
116. Slichter SJ. Evidence-based platelet transfusion guidelines. Hematology 2007;1520:172-8.
117. Spiess BD, Royston D, Levy JH, Fitch J, Dietrich W, Body S, et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 2004;44(8):1143-8.
118. Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll DLA. Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study. Transfusion 2013;53(5):1050-8.
119. Sterne JA, Egger M, Moher D. Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook cochrane.org.
120. Sterne JA, Hernán MA, Reeves C, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016;355:i4919.
121. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007;8:16. [DOI: 10.1186/1745-6215-8-16]
122. Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, et al. Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center Experience. Annals of Oncology 2005;16(1):139-45.
123. Vlaar AP, Juffermans NP. Transfusion-related acute lung injury: a clinical review. Lancet 2013;382(9896):984-94.
124. Weinzierl EP, Arber DA. The differential diagnosis and bone marrow evaluation of new-onset pancytopenia. American Journal of Clinical Pathology 2013;139(1):9-29.
125. Whitaker BI. National blood collection and utilization survey report. Washington, DC: U.S. Department of Health and Human Services; 2013. www.hhs.gov/ash/bloodsafety/2011-nbcus.pdf (accessed 1 December 2016).
126. Zeng Y, Duan X, Xu J, Ni X. TPO receptor agonist for chronic idiopathic thrombocytopenic purpura. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD008235.pub2]
127. Estcourt LJ, Malouf R, Doree C, Trivella M, Hopewell S, Birchall J. Prophylactic platelet transfusions prior to surgery for people with a low platelet count. Cochrane Database of Systematic Reviews 2017, Issue 9. [DOI: 10.1002/14651858.CD012779]